other material
confidence high
sentiment positive
materiality 0.60
Iridex wins broader Medicare coverage for cyclophotocoagulation after LCD appeal
IRIDEX CORP
- Five Medicare Administrative Contractors corrected CPC coverage criteria; 'AND' changed to 'OR', broadening patient access.
- Patient criteria now: failed trabeculectomy/tube shunt, minimal useful vision with elevated IOP, or need pain relief.
- CEO David Bruce thanked MACs for quick action; appeal supported by Dr. Shan Lin, co-author of the 2001 AAO paper.
- Iridex preparing subsequent appeal to further cover poor surgical candidates and emergency situations.
- Change aligns LCDs with 2001 AAO paper; Iridex cites 22 years of technological advances and clinical studies.